A survey of in vivo diode dosimetry in the UK

Journal of Radiotherapy in Practice

Volumn 1, Issue 2, 1999, Pages 73-82

  Appleyard, Robert ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

diodes; In vivo dosimetry; quality assurance

Indexed keywords

EID: 85007998634     PISSN: 14603969     EISSN: 14671131     Source Type: Journal    
DOI: 10.1017/S1460396999000138     Document Type: Article

References (17)

1. Harris NL, JafFe ES, Stein H, et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
2. National Cancer Institute: NCI-sponsored study of classification of non-Hodgkin's lymphoma. Summary and description of a Working Formulation for clinical usage. The non-Hodgkin's lymphoma pathologic classification project. Cancer 1982; 49: 2112-2135.
3. Lawrence TS, Urba WJ, Steinberg SM, et al. Retrospective analysis of stages I and II indolent lymphomas at the National Cancer Institute. Int J Rad Oncol Biol Phys 1988; 14(3): 417-424.
4. Denham JW, Denham E, Dear KB, et al. The follicular non-Hodgkin's lymphomas-1. The possibility of cure. EurJ Cancer 1996; 32A(3): 470-479.
5. Sutcliffe SB, Gospodarowicz M, Bush RS, et al. Role of radiation therapy in localised non-Hodgkin's lymphoma. Radiotherapy and Oncology 1985; 4: 211-223.
6. Wylie JP, Cowan RA, Deakin DR The role of radiotherapy in the treatment of localised intermediate and high grade non-Hodgkin's lymphoma in elderly patients. Radiotherapy and Oncology 1998; 49(1): 9-14.
7. Hudson BV, Hudson GV, MacLennan KA, et al. Clinical Stage 1 non-Hodgkin's lymphoma: long term follow-up patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial treatment. Br J Cancer 1993; 69(6): 1088-1093.
8. Lamb DS, Vaughan HG, Easterling M, et al. Localised grade 2 non-Hodgkin's lymphoma: Results of treatment with radiotherapy (BNLI report No. 24). Clin Radiol 1984; 35: 253-260.
9. Van der Maazen RWM, Noordijk EM, Thomas J, et al. Combined modality treatment is the treatment of choice for stage I/IE intermediate and high grade non-Hodgkin's lymphomas. Radiotherapy and Oncology 1998; 49(1): 1-7.
10. Miller TP, Dahlberg S, Cassady JR, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localised intermediate- and high-grade non-Hodgkin's Lymphoma. New Engl J Med 1998; 339(1): 21-26.
11. Glick JH, Kim K, Earle J, et al. An ECOG randomised phase III trial of CHOP vs CHOP + radiotherapy (XRT) for intermediate grade early stage non-Hodgkin's lymphoma (NHL). Proc Am Soc Clin Oncol 1995; 14: A-1221; 391.
12. MacManus MP, Hoppe RT. Is radiotherapy curative for stage 1 and II low grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996; 14 (4): 1282-1290.
13. Young W, Meredith C. Radiotherapy dose and fractionation regimens prescribed for non-Hodgkin's lymphoma (a local study). Journal of Radiotherapy in Practice 1999; 1: 65-72.
14. Longo DL, Glatstein E, Duffey PL, et al. Treatment of localised aggressive lymphomas with combination chemotherapy followed by involved field radiation therapy. J Clin Oncol 1989; 7(9): 1295-1302.
15. Gospoarowicz MK, Wasserman TH. Non-Hodgkin's Lymphomas. In: Perez CA and Brady LW (ed) Principles and Practice of Radiation Oncology, 3rd edn., 1997: 1987-2012.
16. Physcian PDQ: Adult non-Hodgkin's lymphoma. National Cancer Institute 2000. www.graylab.ac.uk.
17. BNLI Randomised trial of radiation dose in non-Hodgkin's lymphoma (Study Protocol) BNLI, London. January 1997.